Burkitt's lymphoma in adults with and without human immunodeficiency virus infection: A single-institution clinicopathologic study of 75 patients

Cancer

Volumn 82, Issue 4, 1998, Pages 766-774

  Spina, Michele ^a   Tirelli, Umberto ^a   Zagonel, Vittorina ^a   Gloghini, Annunziata ^a   Volpe, Rachele ^a   Babare, Roberta ^a   Abbruzzese, Luciano ^a   Talamini, Renato ^a   Vaccher, Emanuela ^a   Carbone, Antonino ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Adults; Burkitt's lymphoma; Clinical comparison; General population; Human immunodeficiency virus

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; MITOXANTRONE; PREDNISONE; PROCARBAZINE; TENIPOSIDE; VINCRISTINE; VINDESINE;

ARTICLE; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; COMORBIDITY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; ANTIGENS, NEOPLASM; BURKITT LYMPHOMA; CAUSE OF DEATH; DISEASE-FREE SURVIVAL; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; ITALY; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; SURVIVAL ANALYSIS;

EID: 0032519609     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980215)82:4<766::AID-CNCR21>3.0.CO;2-V     Document Type: Article

References (42)

1. Burkitt D. A sarcoma involving the jaws in African children. Br J Surg 1958; 46:218-23.
2. The non-Hodgkin's lymphoma pathologic classification of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112-35.
3. Hui PK, Feller AC, Lennert K. High-grade non-Hodgkin's lymphoma of B-cell type. Histopathology 1988; 12:127-43.
4. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Clearly ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361-92.
5. Knowles DM, Chamulak GA, Subar M, Burke JS, Dugan M, Wernz J, et al. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): the New York University Medical Center experience with 105 patients (1981-1986). Ann Intern Med 1988; 108:744-53.
6. Raphael M, Gentilhomme O, Tulliez M, Byron PA, Diebold J. Histopathologic features of high-grade non-Hodgkin's lymphomas in acquired immunodeficiency syndrome. Arch Pathol Lab Med 1991; 115:15-20.
7. Carbone A, Tirelli U, Gloghini A, Volpe R, Boiocchi M. Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J Clin Oncol 1993; 11:1674-81.
8. Lennert K, Feller AC. Histopathology of non-Hodgkin's lymphomas (based on the updated Kiel classification). 2nd edition. New York: Springer Verlag, 1992.
9. Levine PH, Connelly RR, Berard CW, O'Connor GT, Dorfman RF, Easton JM, et al. The American Burkitt's lymphoma registry: a progress report. Ann Intern Med 1975; 83:31-6.
10. Philip T. Burkitt's lymphoma in Europe. Lenoir GM, O'Connor GT, Olweny CLM, editors. Burkitt's lymphoma: a human cancer model. Lyon: IARC Scientific Publications, 1985:107-18.
11. Levine AM. Lymphoma in acquired immunodeficiency syndrome. Semin Oncol 1990; 17:104-12.
12. Beral V, Peterman T, Berkelman R, Jaffe H. AIDS-associated non-Hodgkin's lymphoma. Lancet 1991; 337:805-9.
13. Mashal RD, Canellos GP. Small non-cleaved cell lymphoma in adults. Am J Hematol 1991; 38:40-7.
14. Tirelli U, Crivellari D, Galligioni E, Veronesi A, Trovò MG, Tumolo S. Malignant lymphoma, indifferentiated, Burkitt's type in Northeast Italy. J Clin Oncol 1984; 10:129-40.
15. Bernstein JI, Coleman CN, Strickler JG, Dorfman RF, Rosenberg SA. Combined modality therapy for adults with small non-cleaved cell lymphoma (Burkitt's and non-Burkitt's types). J Clin Oncol 1986; 4:847-58.
16. Mazza JJ, Hines JD, Andersen JW, Neiman RS, Mann R, Oken MM, et al. Aggressive chemotherapy in the treatment of Burkitt's and non-Burkitt's undifferentiated lymphoma. Leukemia Lymphoma 1995; 18:289-96.
17. Jost LN, Jacky E, Dommann-Scherrer C, Honegger HP, Maurer R, Sauter C, et al. Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients. Ann Oncol 1995; 6:445-51.
18. 3 ALL in adult patients: a high chance for cure. Ann Hematol 1992; 65:201-5.
19. Straus DJ, Wong GY, Liu J, Oppenberg J, Filippa DA, Gold JWM, et al. Small non-cleaved cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults: results with treatment designed for acute lymphoblastic leukemia. Am J Med 1991; 90:328-37.
20. Lopez TM, Hagemeister FB, McLaughlin P, Velasquez WS, Swan F, Redman JR, et al. Small non-cleaved cell lymphoma in adults: superior results for Stage I-III disease. J Clin Oncol 1990; 8:615-22.
21. Berard C, O'Connor GT, Thomas LB, Torloni H, Lennert K, Lieberman H, et al. Histopathological definition of Burkitt's tumor. Bull World Health Organ 1969; 40:601-7.
22. Carbone A, Tirelli U, Vaccher E, Volpe R, Gloghini A, Bertola G, et al. A clinicopathologic study of lymphoid neoplasias associated with human immunodeficiency virus infection in Italy. Cancer 1991; 68:842-52.
23. Hsu SM, Raine L, Fanger H. A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 1981; 75:734-8.
24. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31:1860-1.
25. Zubrod CG, Schneiderman MA, Frei E, Brindlen C, Lennard Gold G, Shnuder B, et al. Appraisal of methods for the study of chemotherapy in man: comparative therapeutic trial of nitrogen mustard and triethylenethiophosphoramide. J Chron Dis 1960; 11:7.
26. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992: 41(RR-17):1-18.
27. Gisselbrecht C, Oksenhendler E, Tirelli U, Lepage E, Gabarre J, Farcet JP, et al. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy. Am J Med 1993; 95:188-96.
28. Jones SE, Grozea PN, Metz EN, Haut A, Stephens RL, Morrison FS, et al. Superiority of adriamycin containing combination chemotherapy in the treatment of diffuse lymphoma: a Southwest Oncology Group study. Cancer 1979; 43:417-25.
29. Carde P, Meerwaldt JH, van Glabbeke M, Somers R, Monconduit M, Thomas J, et al. Superiority of second over first generation chemotherapy in a randomized trial for stage III-IV intermediate and high grade non-Hodgkin's lymphoma (NHL): the 1980-1985 EORTC trial. Ann Oncol 1991; 2:431-5.
30. Tirelli U, Errante D, Oksenhendler E, Spina M, Vaccher E, Serraino D, et al. Prospective study with combined low-dose chemotherapy and zidovudine in 37 patients with poor prognosis AIDS-related non-Hodgkin's lymphoma. Ann Oncol 1992; 3:843-7.
31. Longo DL, De Vita VT Jr., Duffey PL, Wesley MN, Ihde DC, Hubbard SM, et al. Superiority of ProMACE -CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial. J Clin Oncol 1991; 9:25-38.
32. Tirelli U, Zagonel V, Errante D, Serraino D, Talamini R, De Cicco M, et al. A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavourable non-Hodgkin's lymphoma. J Clin Oncol 1992; 10:228-36.
33. Magrath IT, Janus C, Edwards BK, Spiegel R, Jaffe ES, Berard CW, et al. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 1984; 63:1102-11.
34. Kaplan EL, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958; 53:457-81.
35. Mantel M. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966; 50:163-70.
36. Armitage P, Barry G. 2 × 2 tables and 2 tests. Statistical methods in medical research. 2nd edition. Oxford: Blackwell Scientific Publications, 1987:125-32.
37. Mantel M, Haenszel W. Statistical aspects of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-48.
38. Istituto Superiore di Sanità. Centro Operativo AIDS. Aggiornamento dei casi di AIDS notificati in Italia al 31 dicembre 1995. 1995:1-22.
39. Kaplan LD, Abrams DI, Feigal E, et al. AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA 1989; 261:719-24.
40. Levine AM, Sullivan-Halley J, Pike MC, et al. Human immunodeficiency virus-related lymphoma: prognostic factors predictive of survival. Cancer 1991; 68:2466-72.
41. Vaccher E, Tirelli U, Spina M, Talamini R, Errante D, Simonelli C, Carbone A. Age and serum lactate dehydrogenase level are independent prognostic factors in HIV-related non-Hodgkin's lymphoma: a single institution study of 96 patients. J Clin Oncol 1996; 14:2217-33.
42. Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP, et al. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. N Engl J Med 1997; 336:1641-8.